StockData
Chemomab Therapeutics Ltd. logo

Chemomab Therapeutics Ltd. (CMMB) stock

CMMBNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Mar 23, 2026Score 5/30
$1.62+0.09 (+5.88%)

Close on Nov 16, 2026Market cap $11.65MP/E 1.1Yield –

Chemomab Therapeutics total assets

Total assets on the balance sheet at the end of each period.

Chemomab Therapeutics's total assets was $10.24M at Jun 30, 2026. For fiscal 2025 it was $13.81M, down 18.6% from the year before. The highest annual figure on record is $64.35M in fiscal 2021.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$13.81M-18.6%
FY2024Dec 31, 2024$16.96M-23.4%
FY2023Dec 31, 2023$22.15M-48.6%
FY2022Dec 31, 2022$43.06M-33.1%
FY2021Dec 31, 2021$64.35M+415.8%
FY2020Dec 31, 2020$12.48M-36.8%
FY2019Dec 31, 2019$19.76M+54.8%
FY2018Dec 31, 2018$12.76M+511.5%
FY2017Dec 31, 2017$2.09M–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$10.24M-29.6%
Q4 FY2025Dec 31, 2025$13.81M-37.6%
Q2 FY2025Jun 30, 2025$11.13M-61.4%
Q4 FY2024Dec 31, 2024$16.96M-51.5%
Q2 FY2024Jun 30, 2024$14.54M-66.2%
Q4 FY2023Dec 31, 2023$22.15M-55.9%
Q2 FY2023Jun 30, 2023$28.85M-48.8%
Q1 FY2023Mar 31, 2023$35.01M-42.6%
Q4 FY2022Dec 31, 2022$43.06M-33.1%
Q3 FY2022Sep 30, 2022$50.22M-25.5%
Q2 FY2022Jun 30, 2022$56.38M-20.1%
Q1 FY2022Mar 31, 2022$60.96M+1.4%
Q4 FY2021Dec 31, 2021$64.35M+415.8%
Q3 FY2021Sep 30, 2021$67.44M+777.1%
Q2 FY2021Jun 30, 2021$70.52M+604.1%
Q1 FY2021Mar 31, 2021$60.12M+296.0%
Q4 FY2020Dec 31, 2020$12.48M-36.8%
Q3 FY2020Sep 30, 2020$7.69M-39.7%
Q2 FY2020Jun 30, 2020$10.02M+379.9%
Q1 FY2020Mar 31, 2020$15.18M–
Q4 FY2019Dec 31, 2019$19.76M–
Q4 FY2018Dec 31, 2018$12.76M–
Q4 FY2017Dec 31, 2017$2.09M–

More Chemomab Therapeutics figures

See a number that looks wrong?